Repaglinide
Endocrine System
Drugs used in diabetes
BNF 0601023R0
Data updated May 2026
Download CSV
Repaglinide was ranked 754th of 1,792 medicines by items in May 2026, with 2,050 items, down 40.1% on a year earlier.
2,050items
-40.1%
Dispensed in May 2026
32,029items
Rolling 12 months
£57,049
Net ingredient cost · May 2026
Figure 1. Repaglinide: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to May 2026
Embed this chart
At a glance
- Therapeutic class Drugs used in diabetes
- Presentations 3 shown
- Average cost / item £27.83
- Year on year Down 40.1% on a year earlier
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.
Top presentations, May 2026
The individual products dispensed under Repaglinide this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Repaglinide 1mg tablets | 0601023R0AAABAB | 796 | £30,124 |
| Repaglinide 2mg tablets | 0601023R0AAACAC | 729 | £15,490 |
| Repaglinide 500microgram tablets | 0601023R0AAAAAA | 525 | £11,435 |
Source: NHSBSA Prescription Cost Analysis · to May 2026 OGL v3.0
Where Repaglinide is dispensed
The regions and dispensing practices with the highest Repaglinide volumes.
Top regions
Top dispensing practices
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
Compare Repaglinide with
Other medicines in the same BNF section, by prescribing volume.